chr16-14627161-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PP3PP5
The NM_002582.4(PARN):āc.272A>Gā(p.Tyr91Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000548 in 1,605,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.000092 ( 0 hom., cov: 33)
Exomes š: 0.000051 ( 0 hom. )
Consequence
PARN
NM_002582.4 missense
NM_002582.4 missense
Scores
10
6
3
Clinical Significance
Conservation
PhyloP100: 6.73
Genes affected
PARN (HGNC:8609): (poly(A)-specific ribonuclease) The protein encoded by this gene is a 3'-exoribonuclease, with similarity to the RNase D family of 3'-exonucleases. It prefers poly(A) as the substrate, hence, efficiently degrades poly(A) tails of mRNAs. Exonucleolytic degradation of the poly(A) tail is often the first step in the decay of eukaryotic mRNAs. This protein is also involved in silencing of certain maternal mRNAs during oocyte maturation and early embryonic development, as well as in nonsense-mediated decay (NMD) of mRNAs that contain premature stop codons. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.751
PP5
Variant 16-14627161-T-C is Pathogenic according to our data. Variant chr16-14627161-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 542669.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=2, Pathogenic=2, Likely_pathogenic=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PARN | NM_002582.4 | c.272A>G | p.Tyr91Cys | missense_variant | 5/24 | ENST00000437198.7 | NP_002573.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PARN | ENST00000437198.7 | c.272A>G | p.Tyr91Cys | missense_variant | 5/24 | 1 | NM_002582.4 | ENSP00000387911.2 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152186Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
14
AN:
152186
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000697 AC: 17AN: 243878Hom.: 0 AF XY: 0.0000681 AC XY: 9AN XY: 132178
GnomAD3 exomes
AF:
AC:
17
AN:
243878
Hom.:
AF XY:
AC XY:
9
AN XY:
132178
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000509 AC: 74AN: 1453486Hom.: 0 Cov.: 28 AF XY: 0.0000387 AC XY: 28AN XY: 723262
GnomAD4 exome
AF:
AC:
74
AN:
1453486
Hom.:
Cov.:
28
AF XY:
AC XY:
28
AN XY:
723262
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000919 AC: 14AN: 152304Hom.: 0 Cov.: 33 AF XY: 0.0000940 AC XY: 7AN XY: 74488
GnomAD4 genome
AF:
AC:
14
AN:
152304
Hom.:
Cov.:
33
AF XY:
AC XY:
7
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
9
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:4Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
PARN-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 05, 2024 | Variant summary: PARN c.272A>G (p.Tyr91Cys) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 7e-05 in 243878 control chromosomes. c.272A>G has been reported in the literature in trans along with a pathogenic variant in PARN in two siblings affected with Hoyeraal-Hreidarsson syndrome, other family members carrying this variant reported healthy but had reduced levels of lymphocyte telomeres (example, Dodson_2019). The variant was also reported as a de novo change in one individual from a cohort of Autism patients, without sufficient information for independent analysis (Zhou_2022). These data indicate that the variant may be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal deadenylation activity in vitro (Dodson_2019). The following publications have been ascertained in the context of this evaluation (PMID: 31448843, 35982159). ClinVar contains an entry for this variant (Variation ID: 542669). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Dyskeratosis congenita, autosomal recessive 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | in vitro | Bertuch Lab, Baylor College of Medicine | May 15, 2019 | PARN is a ribodeadenylase. Biallelic PARN variants have been reported in 9 cases of Hoyeraal-Hreidarsson syndrome (HH)/dyskeratosis congenita. Monoallelic PARN variants are associated with IPF and more than 50 cases have been reported. This rare missense variant, p.Y91C, and novel insertion variant, p.I274*, were found in trans in two siblings with HH. Unaffected family members did not have both variants. Functional studies showed that PARN p.Y91C had reduced deadenylase activity and the p.I274* transcript likely underwent NMD. Studies with patient-derived samples showed the expected alteration of PARN target RNAs in one affected sibling. Telomere lengths were extremely short for both affected siblings. However, monoallelic variant carriers had variable telomere length, indicating incomplete penetrance of short telomeres in PARN variant carriers. In summary, this variant has strong evidence for being pathogenic according to ACMG 2015 guidelines and functional data, segregation data, and allelic data. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Mar 09, 2022 | - - |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4;C4225356:Dyskeratosis congenita, autosomal recessive 6 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 05, 2023 | This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 91 of the PARN protein (p.Tyr91Cys). This variant is present in population databases (rs201765587, gnomAD 0.02%). This missense change has been observed in individual(s) with Hoyeraal Hreidarsson syndrome (PMID: 31448843; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 542669). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PARN protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects PARN function (PMID: 31448843). For these reasons, this variant has been classified as Pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 14, 2019 | - - |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 4 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | Jul 05, 2023 | The PARN c.272A>G variant is classified as VUS (PS3_Moderate) The PARN c.272A>G variant is a single nucleotide change in exon 5/24 of the PARN gene, which is predicted to change the amino acid tyrosine at position 91 in the protein to cysteine. This variant is present at low frequency in population databases (gnomAD allele frequency = 0.0091%; 14 het and 0 hom in 152186 sequenced alleles; highest frequency = 0.019%, East Asian population) (PM2 not met). Computational predictions provide conflicting interpretations of pathogenicity for this variant (PP3 and BP4 not met). Functional studies showed that the p.(Tyr91Cys) variant had reduced deadenylase activity (10-fold lower than WT). The Y91C-mutated PARN polypeptide was perturbed in its deadenylation activity and suggest that the PARN-mediated deadenylation activity in individuals in this pedigree carrying the mutation was affected. However, the affected pedigree shows pseudo-dominant inheritance, and the heterozygous carriers of the Y91C variant only displayed reduced telomeres, without bone marrow failure (Dodson et al, 2019; PMID:31448843). (PS3_moderate). The variant has been reported in dbSNP (rs201765587) and in the HGMD database: CM1918160. It has been reported as Pathogenic by other diagnostic laboratories (ClinVar Variation ID: 542669). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
M;.
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at